erythrosine has been researched along with rifamycin b in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Courtois, A; Fardel, O; Guillouzo, A; Lagadic, D; Payen, L | 1 |
| Courtois, A; de Vries, EG; Fardel, O; Guillouzo, A; Payen, L; Vernhet, L | 1 |
2 other study(ies) available for erythrosine and rifamycin b
| Article | Year |
|---|---|
Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells.
Topics: Animals; Animals, Newborn; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Bile Ducts, Intrahepatic; Biological Transport; Blotting, Northern; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Epithelial Cells; Fluoresceins; Indomethacin; Indoprofen; Multidrug Resistance-Associated Proteins; Probenecid; Rats; Rats, Sprague-Dawley; Rifamycins; RNA; Tumor Cells, Cultured | 1999 |
Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells.
Topics: Antibiotics, Antitubercular; ATP-Binding Cassette Transporters; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Fluoresceins; Humans; Lung Neoplasms; Models, Chemical; Multidrug Resistance-Associated Proteins; Rifampin; Rifamycins; Tumor Cells, Cultured | 1999 |